130 related articles for article (PubMed ID: 36773773)
1. Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
Diego-Yagüe I; Mora-Vargas A; Vázquez-Comendador JM; Santamarina-Alcantud B; Fernández-Cruz A; Múñez-Rubio E; Gutiérrez-Villanueva A; Sanchez-Romero I; Moreno-Torres V; Ramos-Martínez A; Calderón-Parra J
Clin Microbiol Infect; 2023 Jun; 29(6):744-750. PubMed ID: 36773773
[TBL] [Abstract][Full Text] [Related]
2. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
3. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
5. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
7. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
8. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores.
Kim SH; Park WB; Lee CS; Kang CI; Bang JW; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Microbiol Infect; 2006 Jan; 12(1):13-21. PubMed ID: 16460541
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Early Oral Switch with β-Lactams for Low-Risk
Bupha-Intr O; Blackmore T; Bloomfield M
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32015029
[TBL] [Abstract][Full Text] [Related]
10. Complicated and uncomplicated S. aureus bacteraemia: an international Delphi survey among infectious diseases experts on definitions and treatment.
Hagel S; Bahrs C; Schumann R; Pletz M; Weis S
Clin Microbiol Infect; 2022 Jul; 28(7):1026.e7-1026.e11. PubMed ID: 35358683
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
12. Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Bigseth RS; Sandholdt H; Petersen A; Østergaard C; Benfield T; Thorlacius-Ussing L
Microbiol Spectr; 2022 Jun; 10(3):e0153021. PubMed ID: 35438533
[TBL] [Abstract][Full Text] [Related]
13. Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.
Willekens R; Puig-Asensio M; Ruiz-Camps I; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Fernández-Hidalgo N; Pigrau C; Almirante B
Clin Infect Dis; 2019 Jul; 69(3):381-387. PubMed ID: 30351401
[TBL] [Abstract][Full Text] [Related]
14. Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.
Hetem DJ; de Ruiter SC; Buiting AGM; Kluytmans JAJW; Thijsen SF; Vlaminckx BJM; Wintermans RGF; Bonten MJM; Ekkelenkamp MB
Medicine (Baltimore); 2011 Jul; 90(4):284-288. PubMed ID: 21694650
[TBL] [Abstract][Full Text] [Related]
15. Safe shortening of antibiotic treatment duration for complicated
Buis D; van Werkhoven CH; van Agtmael MA; Bax HI; Berrevoets M; de Boer M; Bonten M; Bosmans JE; Branger J; Douiyeb S; Gelinck L; Jong E; Lammers A; Van der Meer J; Oosterheert JJ; Sieswerda E; Soetekouw R; Stalenhoef JE; Van der Vaart TW; Bij de Vaate EA; Verkaik NJ; Van Vonderen M; De Vries PJ; Prins JM; Sigaloff K;
BMJ Open; 2023 Apr; 13(4):e068295. PubMed ID: 37085305
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
17. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Cohort Study of Durations of
Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
[TBL] [Abstract][Full Text] [Related]
19. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
20. Increasing numbers and complexity of Staphylococcus aureus bloodstream infection-14 years of prospective evaluation at a German tertiary care centre with multi-centre validation of findings.
Mathé P; Göpel S; Hornuss D; Tobys D; Käding N; Eisenbeis S; Kohlmorgen B; Trauth J; Gölz H; Walker SV; Mischnik A; Peter S; Hölzl F; Rohde AM; Behnke M; Fritzenwanker M; Häcker G; Steffens B; Vehreschild M; Kramme E; Falgenhauer J; Peyerl-Hoffmann G; Seifert H; Rupp J; Gastmeier P; Imirzalioglu C; Tacconelli E; Kern W; Rieg S;
Clin Microbiol Infect; 2023 Sep; 29(9):1197.e9-1197.e15. PubMed ID: 37277092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
